Labiana Health SA

As of December 31, 2025, Labiana Health SA carries a market capitalization of 34.03M, placing it among publicly traded companies globally. Its enterprise value stands at 64.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Labiana Health SA's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, Labiana Health SA has 7.17M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Labiana Health SA maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Labiana Health SA's stock has gained approximately 22.51% over the past 52 weeks. The 50-day moving average sits at 5.92, while the 200-day moving average is 5.80.

As of December 31, 2025, Labiana Health SA holds 5.92M in cash and equivalents against 36.67M in total debt, resulting in a net debt position of 30.09M. Total book value stands at 5.08M, with working capital of 8.87M providing operational flexibility.

Labiana Health SA's most recent stock split took place on February 24, 2026 with a 727:741 split ratio.